此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

SIYA-PT: An Internet-based CBT Intervention to Enhance Low Self-esteem Among Portuguese Emerging Adults

2026年11月6日 更新者:Ivanilda B. Costa、Lusofona University

SIYA-PT: An Internet-based CBT Intervention to Enhance Low Self-esteem

This study investigates whether an eHealth cognitive-behavioural therapy (CBT) intervention for low self-esteem, SIYA-PT, is acceptable and feasible for an ethnically diverse population of emerging adults in Portugal.

研究概览

地位

尚未招聘

条件

干预/治疗

详细说明

Low self-esteem (LSE) is a negative cognitive representation of the self, based on personal experience, and it influences how information is processed.

LSE has been linked to worse psychological adjustment, and research has found that CBT-based interventions using Fennell's cognitive model of low self-esteem were able to improve participants' self-esteem.

SIYA-PT is a cultural adaptation of SIYA, a guided internet-based CBT intervention developed for Swedish adolescents, and it is based on Cognitive Model of Low Self-Esteem, Self-Determination Theory, and Self-Compassion Theory. SIYA-PT has 7 modules that will be presented to participants, one module per week.

The investigators aim to evaluate whether a culturally adapted iCBT intervention is accepted by Portuguese emerging adults - people aged 18 to 29 years old - and whether it is feasible in enhancing self-esteem and improving anxiety and depressive symptoms and quality of life.

This study is a pilot-randomised controlled trial. The study will have an intervention group (IG) that will receive the intervention (SIYA-PT) immediately after randomisation, and a waitlist control group (WCG) that will receive the intervention after follow-up, 3 months after IG finishes their intervention.

The investigators aim to recruit at least 58 participants with LSE, considering a 31% dropout.

The main outcomes of the study are self-esteem, quality of life and anxiety and depressive symptoms and the secondary outcomes are self-compassion and assertiveness.

研究类型

介入性

注册 (估计的)

58

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 29年 (成人)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Scores of ≤15 on the Rosenberg Self-esteem Scale and <120 on the Robson Self-concept Questionnaire indicating low self-esteem;
  • Scores of ≤ 50 on the WHOQOL-BREF indicating low quality of life
  • Age between 18 and 29 years old
  • Fluency in written and spoken Portuguese
  • Daily access to a device with an internet connection
  • Not receiving any psychological intervention
  • If on psychopharmacological treatment, must be in treatment for at least three months and the dosage must be stable for at least one month
  • Residence in Portugal

Exclusion Criteria:

  • Severe psychiatric disorders such as Depressive Disorder or Suicidal ideation, which will be self-reported on the Sociodemographic Questionnaire and assessed through a Structured Interview developed by the research team
  • Alcohol Use Disorder, which will be assessed using the Alcohol Use Disorder Identification Test
  • Personal relationship with PHD student (e.g., former patients or students, friends, family members)

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Intervention Group (IG)

IG will have access to the intervention (SIYA-PT). The participants will have an individual login to use the platform, and have access to the modules and the measures that need to be filled out throughout the study.

SIYA-PT has seven modules:

Module 1 - Introduction Module 2 - Achievements and self-esteem Module 3 - Relationships and self-esteem Module 4 - Independence and self-esteem Module 5 - Dealing with adversities Module 6 - Self-acceptance Module 7 - Termination and continuation

其他:Waitlist Control Group (WCG)

WCG will not receive the intervention while IG goes through SIYA-PT. The participants will have an individual login to access the platform to answer the self-reported measures weekly to monitor their well-being. The participants will also have access to messaging to be able to contact the clinical psychologist on the platform if there is increase in their, e.g., anxiety and depressive symptoms. After the end of IG intervention and the follow-up , three months, WCG will receive the same SIYA-PT intervention.

SIYA-PT has seven modules:

Module 1 - Introduction Module 2 - Achievements and self-esteem Module 3 - Relationships and self-esteem Module 4 - Independence and self-esteem Module 5 - Dealing with adversities Module 6 - Self-acceptance Module 7 - Termination and continuation

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
The Rosenberg Self-esteem Scale (RSE)
大体时间:Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up

A 10-item self-report measure to assess global self-esteem. The RSE (Rosenberg, 1965; Pechorro et al., 2011) uses a 4-point Likert scale to rate agreement with the statements, from 0 (Strongly disagree) to 3 (Strongly agree). Scores vary from 0 to 30, with higher scores indicating higher levels of global self-esteem.

Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up
Robson Self-Concept Questionnaire (RSCQ)
大体时间:Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up

A 30-item self-report measure to assess global self-esteem. The RSCQ (Robson, 1989) uses a 7-point Likert scale to rate agreement with each statement, from 0 (Completely disagree) to 7 (Completely agree). Scores vary from 0 to 210, with higher scores indicating higher levels of global self-esteem.

Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up
Generalised Anxiety Disorder 7-item Scale (GAD-7)
大体时间:Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up

A seven-item self-report measure to assess generalised anxiety disorder according to DSM-IV criteria. GAD-7 (Spitzer et al., 2006; Sousa et al., 2015) uses a 4-point Likert scale to rate how often one has experienced the described situation, from 0 (Never) to 3 (Almost every day). Scores vary from 0 to 21, with higher scores indicating higher levels of anxiety.

Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up
Patient Health Questionnaire 9-item (PHQ-9)
大体时间:Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up

A nine-item self-report measure to assess depressive symptoms according to DSM-IV criteria. PHQ-9 (Kroenke et al., 2001; Lamela et al., 2020) uses a 4-point Likert scale to rate how often one has experienced the described situation, from 0 (Never) to 3 (Almost every day). Scores vary from 0 to 27, with higher scores indicating higher levels of depressive symptoms.

Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up
WHOQOL-BREF
大体时间:Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up

A 26-item self-report measure with four domains (physical health, psychological health, social relationships and environment) to assess perceived quality of life. WHOQOL-BREF (The WHOQOL Group, 1998; Vaz Serra et al., 2006) uses a 5-point Likert scale, from 1 ("Very Poor", "Not at all" or "Very dissatisfied") to 5 ("Very good", "Completely", "Always" or "Very satisfied") to ask how one feels about their quality of life, health, or other areas of their life. Scores vary from 0 to 100, with higher scores indicating higher perceived quality of life.

Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up

次要结果测量

结果测量
措施说明
大体时间
Self-Compassion Scale (SCS)
大体时间:Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up

A 26-item self-report measure with six subscales (Self-Kindness, self-judgment, common humanity, isolation, mindfulness, and over-identification) that assesses how one typically responds in difficult times in terms of self-compassion. SCS (Neff, 2003; Castilho & Pinto-Gouveia, 2015) uses a 5-point Likert scale to rate how often one does each behaviour described in each item, from 1 (Almost never) to 5 (Almost always). Higher scores indicate higher levels of self-compassion.

Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up
The Rathus Assertiveness Schedule (RAS)
大体时间:Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up

A 30-item self-report measure to assess assertive behaviour. RAS (Rathus, 1973; Detry & Castro, 1990) uses a 6-point Likert scale to rate how well each item describes the person, from 5 (Very much like me) to 0 (Very much unlike me). Scores vary from 0 to 30, with higher scores indicating higher assertiveness.

Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up

其他结果措施

结果测量
措施说明
大体时间
Alcohol Use Disorder Identification Test (AUDIT)
大体时间:pre-intervention (baseline)

A 10-item self-report measure to screen for three areas (alcohol consumption, dependence symptoms and alcohol-related problems) of alcohol-use-related problems using a 5-point Likert scale. AUDIT (WHO, 1989) scores vary from 0 to 40, from 0 to 4, with higher scores indicating higher levels of alcohol-use-related problems.

pre-intervention (baseline)
Structure interview
大体时间:pre-intervention (baseline)

An interview guide with 14 questions developed by the research team based on questions from Mini International Neuropsychiatric Interview (Sheehan et al., 1998)'s subscale for Suicide Ideation and DSM-5-TR criteria for Major Depressive Disorder with a dichotomous answer - No or Yes.

pre-intervention (baseline)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

合作者

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2027年1月1日

初级完成 (估计的)

2027年11月30日

研究完成 (估计的)

2027年11月30日

研究注册日期

首次提交

2026年11月3日

首先提交符合 QC 标准的

2026年11月6日

首次发布 (实际的)

2026年11月13日

研究记录更新

最后更新发布 (实际的)

2026年11月13日

上次提交的符合 QC 标准的更新

2026年11月6日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

其他研究编号

  • 2024.00914.BD
  • 2024.00914.BD (其他赠款/资助编号:Fundação para a Ciência e a Tecnologia)
  • https://doi.org/10.54499/2024. (其他标识符:Fundação para a Ciência e a Tecnologia)

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

Study participants have not given consent for their individual data to be shared with other researchers.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.